Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters

BACKGROUND: Despite modern chemotherapy regimens, survival of pancreatic cancer patients remains dismal. Toxicity is a major concern and it is a challenge to upfront identify patients with the highest benefit from aggressive polychemotherapy. We aimed to evaluate ORR and side effects of the FOLFIRIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlick, Konstantin, Magnes, Teresa, Ratzinger, Lukas, Jaud, Bernhard, Weiss, Lukas, Melchardt, Thomas, Greil, Richard, Egle, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226156/
https://www.ncbi.nlm.nih.gov/pubmed/30412592
http://dx.doi.org/10.1371/journal.pone.0206688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226156/
https://www.ncbi.nlm.nih.gov/pubmed/30412592
http://dx.doi.org/10.1371/journal.pone.0206688

Ejemplares similares